现行宫颈癌筛查指南。
Current Cervical Carcinoma Screening Guidelines.
作者信息
Schlichte Megan J, Guidry Jacqueline
机构信息
Baylor College of Medicine, 1 Baylor Plaza, Houston, TX 77030, USA.
Center for Clinical Studies, 6655 Travis St #120, Houston, TX 77030, USA.
出版信息
J Clin Med. 2015 May 7;4(5):918-32. doi: 10.3390/jcm4050918.
Abstract
A formidable threat to the health of women, cervical carcinoma can be prevented in many cases with adequate screening. The current guidelines for cervical carcinoma screening were created as joint recommendations of the American Cancer Society (ACS), the American Society for Colposcopy and Cervical Pathology (ASCCP) and the American Society for Clinical Pathology (ASCP) in 2012, and later accepted and promoted by the American Congress of Obstetricians and Gynecologists (ACOG). The 2012 recommendations underscore the utility of molecular testing as an adjunct to cytology screening for certain women and provide guidance to clinicians based on different risk-benefit considerations for different ages. This manuscript will review screening techniques and current recommendations for cervical cancer screening and human papilloma virus (HPV) testing, as well as possible future screening strategies.
摘要
宫颈癌是对女性健康的一大威胁，但在许多情况下，通过充分的筛查可以预防。当前的宫颈癌筛查指南是由美国癌症协会（ACS）、美国阴道镜及宫颈病理学会（ASCCP）和美国临床病理学会（ASCP）于2012年联合发布的建议，后来被美国妇产科医师学会（ACOG）接受并推广。2012年的建议强调了分子检测作为某些女性细胞学筛查辅助手段的实用性，并根据不同年龄的不同风险效益考虑为临床医生提供指导。本文将回顾宫颈癌筛查和人乳头瘤病毒（HPV）检测的筛查技术及当前建议，以及可能的未来筛查策略。
相似文献
1
Current Cervical Carcinoma Screening Guidelines.现行宫颈癌筛查指南。
J Clin Med. 2015 May 7;4(5):918-32. doi: 10.3390/jcm4050918.
3
ACOG Practice Bulletin Number 131: Screening for cervical cancer.ACOG 实践通报第 131 号：宫颈癌筛查。
Obstet Gynecol. 2012 Nov;120(5):1222-38. doi: 10.1097/aog.0b013e318277c92a.
4
Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening.人乳头瘤病毒DNA检测作为子宫颈细胞学筛查辅助手段的临时指南。
Obstet Gynecol. 2004 Feb;103(2):304-9. doi: 10.1097/01.AOG.0000109426.82624.f8.
5
Making Sense of Cervical Cancer Screening Guidelines and Recommendations.解读宫颈癌筛查指南与建议
Curr Treat Options Oncol. 2015 Dec;16(12):55. doi: 10.1007/s11864-015-0373-1.
6
Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance.原发性高危型人乳头瘤病毒检测用于宫颈癌筛查：临时临床指南
J Low Genit Tract Dis. 2015 Apr;19(2):91-6. doi: 10.1097/LGT.0000000000000103.
7
Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance.用于宫颈癌筛查的主要高危型人乳头瘤病毒检测：临时临床指南。
Gynecol Oncol. 2015 Feb;136(2):178-82. doi: 10.1016/j.ygyno.2014.12.022. Epub 2015 Jan 8.
8
Practice Bulletin No. 168 Summary: Cervical Cancer Screening and Prevention.第168号实践公告摘要：宫颈癌筛查与预防
Obstet Gynecol. 2016 Oct;128(4):923-925. doi: 10.1097/AOG.0000000000001699.
9
Guidelines for screening and treatment of cervical disease in the adolescent.青少年宫颈疾病筛查与治疗指南。
J Pediatr Adolesc Gynecol. 2004 Oct;17(5):303-11. doi: 10.1016/j.jpag.2004.07.008.
引用本文的文献
1
Prognostic value of APOBEC3A in patients with cervical squamous cell carcinoma in a major urban center in China: a retrospective study.中国某主要城市中心宫颈鳞状细胞癌患者中载脂蛋白B mRNA编辑酶催化多肽样3A（APOBEC3A）的预后价值：一项回顾性研究
Transl Cancer Res. 2023 Oct 31;12(10):2673-2681. doi: 10.21037/tcr-23-383. Epub 2023 Oct 16.
2
Colposcopic accuracy in diagnosing squamous intraepithelial lesions: a systematic review and meta-analysis of the International Federation of Cervical Pathology and Colposcopy 2011 terminology.阴道镜检查诊断鳞状上皮内病变的准确性：国际宫颈病理学会和阴道镜学会 2011 年术语学的系统评价和荟萃分析。
BMC Cancer. 2023 Feb 23;23(1):187. doi: 10.1186/s12885-023-10648-1.
3
Routine Pap smear screening in Pakistan: A current perspective.
Ann Med Surg (Lond). 2022 Sep 21;83:104498. doi: 10.1016/j.amsu.2022.104498. eCollection 2022 Nov.
4
Ghanaian women's perception on cervical cancer threat, severity, and the screening benefits: A qualitative study at Shai Osudoku District, Ghana.加纳女性对宫颈癌威胁、严重程度及筛查益处的认知：加纳沙伊奥苏杜库区的一项定性研究
Public Health Pract (Oxf). 2022 May 16;3:100274. doi: 10.1016/j.puhip.2022.100274. eCollection 2022 Jun.
5
Cues to cervical cancer screening and reaction to cervical cancer diagnosis during screening among women in Shai Osudoku District, Ghana.加纳沙伊奥苏多库区女性宫颈癌筛查的提示因素及筛查期间对宫颈癌诊断的反应
Ecancermedicalscience. 2022 May 19;16:1392. doi: 10.3332/ecancer.2022.1392. eCollection 2022.
6
Perceived Barriers to Cervical Cancer Screening Uptake among Women of an Urban Community in South-Eastern Nigeria.尼日利亚东南部一城市社区女性对宫颈癌筛查接受度的感知障碍。
Asian Pac J Cancer Prev. 2022 Jun 1;23(6):1959-1965. doi: 10.31557/APJCP.2022.23.6.1959.
7
Methodologies of Primary HPV Testing Currently Applied for Cervical Cancer Screening.目前应用于宫颈癌筛查的原发性人乳头瘤病毒检测方法
Life (Basel). 2020 Nov 19;10(11):290. doi: 10.3390/life10110290.
8
Comparison of Diagnostic Methods in Detection of Squamous Cell Abnormalities in Iranian Women with Abnormal Pap's Smear Test and Associated Demographic and Issues.伊朗巴氏涂片检查异常女性鳞状细胞异常检测中诊断方法的比较及相关人口统计学和问题
Iran J Pathol. 2020 Spring;15(2):106-116. doi: 10.30699/ijp.2020.114626.2248. Epub 2020 Feb 19.
9
Use of Short Messaging Service to Improve Follow-Up for Abnormal Pap Test Results in Minority and Medically Underserved Women in North Carolina: Questionnaire on Attitudes and Acceptability.利用短消息服务改善北卡罗来纳州少数族裔及医疗服务不足女性的巴氏试验异常结果随访情况：态度与可接受性调查问卷
JMIR Form Res. 2019 Aug 6;3(3):e12675. doi: 10.2196/12675.
10
Cervical Cancer Screening Programs in Europe: The Transition Towards HPV Vaccination and Population-Based HPV Testing.欧洲的宫颈癌筛查项目：向 HPV 疫苗接种和基于人群的 HPV 检测的转变。
Viruses. 2018 Dec 19;10(12):729. doi: 10.3390/v10120729.
本文引用的文献
1
Diagnostic performance of HPV E6/E7, hTERT, and Ki67 mRNA RT-qPCR assays on formalin-fixed paraffin-embedded cervical tissue specimens from women with cervical cancer.人乳头瘤病毒E6/E7、人端粒酶逆转录酶（hTERT）和Ki67 mRNA逆转录定量聚合酶链反应（RT-qPCR）检测对宫颈癌女性福尔马林固定石蜡包埋宫颈组织标本的诊断效能
Exp Mol Pathol. 2015 Jun;98(3):510-6. doi: 10.1016/j.yexmp.2015.03.036. Epub 2015 Mar 31.
2
Vaccination coverage among adults, excluding influenza vaccination - United States, 2013.成年人疫苗接种率（不包括流感疫苗）- 美国，2013 年。
MMWR Morb Mortal Wkly Rep. 2015 Feb 6;64(4):95-102.
3
Cancer screening in the United States, 2015: a review of current American cancer society guidelines and current issues in cancer screening.美国 2015 年癌症筛查：对当前美国癌症协会指南和癌症筛查中当前问题的回顾。
CA Cancer J Clin. 2015 Jan-Feb;65(1):30-54. doi: 10.3322/caac.21261. Epub 2015 Jan 8.
4
Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance.原发性高危型人乳头瘤病毒检测用于宫颈癌筛查：临时临床指南
Obstet Gynecol. 2015 Feb;125(2):330-337. doi: 10.1097/AOG.0000000000000669.
5
Evaluation of p16, human papillomavirus capsid protein L1 and Ki-67 in cervical intraepithelial lesions: potential utility in diagnosis and prognosis.p16、人乳头瘤病毒衣壳蛋白L1和Ki-67在宫颈上皮内病变中的评估：在诊断和预后中的潜在应用
Pathol Res Pract. 2014 Dec;210(12):916-21. doi: 10.1016/j.prp.2014.07.007. Epub 2014 Jul 30.
6
Cobas HPV test for first-line screening for cervical cancer.用于宫颈癌一线筛查的 cobas HPV 检测
J Community Support Oncol. 2014 May;12(5):156-7. doi: 10.12788/jcso.0039.
7
State of the science: cervical cancer screening in transition.科学现状：宫颈癌筛查处于变革之中。
Gynecol Oncol. 2014 Jun;133(3):389-93. doi: 10.1016/j.ygyno.2014.04.040.
8
Disagreement between human papillomavirus assays: an unexpected challenge for the choice of an assay in primary cervical screening.人乳头瘤病毒检测结果不一致：初次宫颈癌筛查中检测方法选择面临的意外挑战。
PLoS One. 2014 Jan 20;9(1):e86835. doi: 10.1371/journal.pone.0086835. eCollection 2014.
9
Assessing the impact of new cervical cancer screening guidelines.评估新的宫颈癌筛查指南的影响。
MLO Med Lab Obs. 2013 Feb;45(2):28-9.
10
Challenges in cervical cancer prevention: a survey of U.S. obstetrician-gynecologists.宫颈癌防治面临的挑战：对美国妇产科医生的调查。
Am J Prev Med. 2013 Aug;45(2):175-81. doi: 10.1016/j.amepre.2013.03.019.
Zotero 插件